Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Short Interest Update

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 4,200 shares, a growth of 133.3% from the October 31st total of 1,800 shares. Based on an average daily trading volume, of 26,600 shares, the days-to-cover ratio is presently 0.2 days.

Scinai Immunotherapeutics Stock Down 0.6 %

Shares of NASDAQ SCNI traded down $0.02 during trading on Thursday, reaching $3.46. The company had a trading volume of 40,172 shares, compared to its average volume of 298,630. Scinai Immunotherapeutics has a 12 month low of $2.23 and a 12 month high of $8.92. The stock has a market cap of $2.01 million, a P/E ratio of -0.01 and a beta of 2.46. The company’s fifty day moving average price is $3.49 and its 200-day moving average price is $3.69.

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications.